3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Pain
2
Visceral Pain
1
Persistent Postoperative Pain
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Neuralgia
1
Neoplasms
1
Lymphoma
1
Leiomyoma
1
Earache
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Cyclophosphamide
3
Zoledronic Acid
2
Vincristine
2
Tranexamic Acid
2
Temozolomide
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Ibandronic Acid
2
Etoposide
2
Doxorubicin
2
samarium Sm-153 lexidronam
1
robatumumab
1
pegfilgrastim
1
eltrombopag
1
delta 24-sterol reductase
1
Sodium Pertechnetate Tc 99m
1
Sodium Chloride
1
Samarium
1
Radiation
1
Pregabalin
1
Plicamycin
1
Neutrons
1
Ifosfamide
1
Histocompatibility Testing
1
Guanabenz
1
Gemcitabine
1
Fluoridation
1
Fibrin Tissue Adhesive
1
Etanercept
1
Diathermy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Bone Neoplasms
×
Pregabalin
×
Clear all
NCT00381095
2021-01-20
COPE
Pfizer
Phase 4
Terminated
152 enrolled
14 charts